Mutares Tenders €25M in Bonds as SABIC Megadeal Looms on the Horizon
08.05.2026 - 14:51:18 | boerse-global.de
The Munich-based holding company is taking a two-pronged approach to its balance sheet: trimming expensive debt while preparing for the largest acquisition in its history. Mutares has launched a tender offer for up to €25 million of its Nordic bond due 2027, offering holders 101 percent of par value plus accrued interest.
The buyback window opens on Monday, 11 May 2026, with bondholders given until 2 June to tender their notes. Pareto Securities is handling the settlement, and Mutares expects to pay out on 5 June. The move targets no more than a tenth of the outstanding bond volume, but it marks the beginning of a more aggressive deleveraging campaign.
Debt reduction with a purpose
The tender is no routine capital management exercise. Mutares disclosed in its 2025 annual report that it had breached a covenant on the ratio of net debt to equity. Since then, management has been scrambling to repair the damage. The goal is to cut the holding company's bond debt from roughly €385 million today to between €250 million and €300 million by the end of 2026.
Should investors sell immediately? Or is it worth buying Mutares?
The cash for the buyback comes from a recently completed capital raising that generated around €105 million in gross proceeds. Starting this quarter, Mutares plans to repurchase tranches of at least €25 million on a regular basis. The company believes the SABIC transaction — once closed — will itself bring the net debt metric back inside covenant limits by the end of the first half of 2026.
The SABIC gamble
Mutares is taking over SABIC's Engineering Thermoplastics business, a deal valued at roughly €2.5 billion in annual revenue. It represents the holding company's biggest-ever acquisition and will serve as the cornerstone of a new "Chemicals & Materials" segment. Closing is expected in the second half of 2026.
The timing is ambitious. The Q1 report, due on Tuesday, 12 May, should offer early clues on whether the integration timeline is realistic. For the full year 2026, Mutares targets group revenue between €7.9 billion and €9.1 billion, with holding net profit in a range of €165 million to €200 million.
Stock languishes despite analyst optimism
Mutares at a turning point? This analysis reveals what investors need to know now.
The market has yet to reward the narrative. Mutares shares slipped 0.4 percent on Friday to €26.05, bringing the year-to-date decline to roughly 13 percent. The stock has recovered about 7.5 percent over the past seven days, but it remains more than 20 percent below its 52-week high of €36.75.
Analysts see a disconnect. The average price target stands at €47.50, implying upside of more than 70 percent from current levels. The bond buyback, they argue, strengthens the financial foundation for the quarters ahead — provided the SABIC integration doesn't throw up unexpected hurdles.
Management is betting on a long-term growth trajectory of 25 percent annually through 2030, driven largely by expansion in North America and Asia. Whether that plan holds together depends heavily on how smoothly the chemicals business is folded into the portfolio. The next earnings release will offer the first real test.
Ad
Mutares Stock: New Analysis - 8 May
Fresh Mutares information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
So schätzen die Börsenprofis Mutares Aktien ein!
FĂĽr. Immer. Kostenlos.
